 |
| PZOO Issues New Interview on Nevada Market |
|
 Hot Stock to Watch |
Company: Pazoo Inc. (OTCQB: PZOO)
|
Last:
Price: 0.0355
Change (%): - 0.001 (2.74)
Volume: 1,138,194 |
 |
Pazoo Radio Episode 4 Featuring MA and Associates CEO Antonio Del Hierro, Pazoo's Medical Marijuana Testing Laboratory Partner in Nevada, Now Available at Pazoo.com
WHIPPANY, NJ / ACCESSWIRE / November 5, 2014 / Pazoo, Inc. (OTCQB: PZOO) (German WKN#: A1J3DK), is pleased to announce its fourth Pazoo Radio episode is now available for download at www.pazoo.com by clicking on the Pazoo Radio tab on the upper right hand side of the home page. On this episode, Pazoo CEO David Cunic and co-host Chris Curran of Fractal Recording welcome Antonio Del Hierro - CEO and President of MA & Associates - who discusses his firm’s recent licensing as an official medical marijuana testing lab in the State of Nevada.
As the major shareholder in MA & Associates (40%), Pazoo is excited about being in on the ground floor of this burgeoning industry. Mr. Del Hierro made it clear that MA & Associates doesn’t grow marijuana or sell marijuana; that the lab’s mission is to ensure that all marijuana products meet high standards for safety and potency, similar to prescription and OTC drugs.
MA & Associates is Pazoo’s first foray into medical marijuana testing. The health and wellness company announced this week that it has increased its stake to 55 percent in Harris Lee, LLC, a firm created to set up medical marijuana testing laboratories across the U.S. and Canada. Now legal in 23 states, including Washington, DC, universal testing of marijuana products has a bright future.
As a reminder, at the upcoming 3rd Annual Marijuana Business Conference & Expo in Las Vegas, Pazoo and MA & Associates will be hosting Pazoo Fest, a party at the New York-New York Hotel and Casino on Nov 13th. If you would like to join us at Pazoo Fest please send your name and email to investor@pazoo.com for details.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
